Research Article

The Contribution of Drugs and Helicobacter pylori to Gastric Mucosa Changes in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome

Table 3

Detection rates of Helicobacter pylori, HSV-1, CMV, and their combinations in various gastric mucosal damages, as evidenced by esophagogastroduodenoscopy.

Gastric mucosa status H. pylori HSV-1CMV H.pylori + HSV-1 + CMV
(n = 29)(n = 7)(n = 3)(n = 36)

Antral gastritis, n ()26 (89.7)7 (100.0)3 (100.0)28 (77.8)
Pangastritis, n ()4 (13.8)003 (8.3)
Gastric mucosal erosion, n ()8 (27.6)2 (28.6)09 (25.0)
Gastric mucosal hemorrhage, n ()4 (13.8)2 (28.6)01 (2.8)
Intact gastric mucosa, n ()1 (3.4)1 (14.3)04 (11.1)

Note: The percentage of positive results was calculated from the number of patients having an infectious agent.